Literature DB >> 16024076

Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment.

A Dion1, M Langman, G Hall, M Filiaggi.   

Abstract

Calcium polyphosphate (CPP) antibiotic delivery matrices were prepared using a unique processing technique involving the exposure of antibiotic-loaded CPP pastes to high humidity for 0, 5, or 24 h. After the designated gelling period, samples were dried for a minimum of 24 h. At several time points out to 130 h, the elution medium was monitored for vancomycin, Ca2+ ion and ortho and poly phosphate release levels. Vancomycin activity was also assessed after 1, 24 and 130 h, while solution 31P-NMR was used to monitor changes in chain length within a 24 hr gelled VCM disc throughout the elution process. The gelling and drying process significantly reduced the rate of vancomycin release during the initial 2-4 h of elution, while extending the effective antibiotic release period by an additional 80 h. The mild conditions associated with matrix fabrication readily allowed for vancomycin incorporation within an environment that did not disrupt antibiotic activity. Throughout the elution process, all sample groups experienced considerable swelling followed by some apparent bulk erosion. Phosphate chain lysis was clearly observed by the end of the elution period. Generally, no strong or consistent correlation existed between matrix degradation and antibiotic release for the treatment groups investigated. An ability to delay antibiotic release using CPPs in conjunction with this protocol supports further investigations into the potential of this matrix as a localized drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024076     DOI: 10.1016/j.biomaterials.2005.05.072

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Application of K/Sr co-doped calcium polyphosphate bioceramic as scaffolds for bone substitutes.

Authors:  Huixu Xie; Qianbin Wang; Qingsong Ye; Changxiu Wan; Longjiang Li
Journal:  J Mater Sci Mater Med       Date:  2012-02-05       Impact factor: 3.896

2.  Vancomycin containing PLLA/β-TCP controls MRSA in vitro.

Authors:  Berna Kankilic; Erdal Bayramli; Emine Kilic; Sezin Dağdeviren; Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2011-09-15       Impact factor: 4.176

3.  Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model.

Authors:  Christian Fölsch; Maike Federmann; Klaus D Kuehn; Clemens Kittinger; Stefan Kogler; Gernot Zarfel; Martina Kerwat; Steve Braun; Susanne Fuchs-Winkelmann; Jürgen R J Paletta; Philip P Roessler
Journal:  Int Orthop       Date:  2014-11-08       Impact factor: 3.075

4.  Effect of polymerization degree of calcium polyphosphate on its microstructure and in vitro degradation performance.

Authors:  Yu Long Ding; Yuan Wai Chen; Ying Jie Qin; Guo Qi Shi; Xi Xun Yu; C X Wan
Journal:  J Mater Sci Mater Med       Date:  2007-08-23       Impact factor: 3.896

5.  Antibacterial and anticancerous drug loading kinetics for (10-x)CuO-xZnO-20CaO-60SiO2-10P2O5 (2 ≤ x ≤ 8) mesoporous bioactive glasses.

Authors:  Shikha Garg; Swati Thakur; Aayush Gupta; Gurbinder Kaur; Om Prakash Pandey
Journal:  J Mater Sci Mater Med       Date:  2016-12-09       Impact factor: 3.896

6.  Silver-Doped Calcium Phosphate Bone Cements with Antibacterial Properties.

Authors:  J V Rau; M Fosca; V Graziani; A A Egorov; Yu V Zobkov; A Yu Fedotov; M Ortenzi; R Caminiti; A E Baranchikov; V S Komlev
Journal:  J Funct Biomater       Date:  2016-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.